Wednesday, 1 November, 2017
"Food companies, big pharma and chemical/biotech companies have been targeting the modern nutraceuticals market since its nascent beginnings. No wonder. According to Mordor Intelligence, the global nutraceutical market was valued at us$205.4 billion in 2016 and is expected to soar to us$294.79 billion by 2022.
Our core mission is to develop and test natural ingredients with anti-ageing benefits, says Edwards. “Companies using our first-in-class Chronoscreen™ platform, which evaluates biological activity, can develop or re-formulate their own enhanced performance products. We have tested hundreds of products in collaboration with global partners, notably in the US, Europe and Asia, and have a strong internal pipeline to support product development for manufacturers and suppliers. The approach is also showing great promise in the assessment of probiotic supplements; a category that is increasingly being recognised as having the potential to have an immense impact on human health and is growing at 10% per annum in key markets. The use of in vivo models on the Chronoscreen™ platform allows us to not only discover new nutraceutical ingredients, but also identify novel applications for existing ones”.
Read the full article here.